Genotoxic and non-genotoxic Impurities in pharmaceuticals current regulations, status and trend

Chimica Oggi

Volumn 27, Issue 2, 2009, Pages

  Roy, Arindam ^a   Nyarady, Stefan ^a   Matchett, Michael ^a  

^a Center for Analytical Research Covidien   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649878788     PISSN: 0392839X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. www.fda.gov/cder
2. www.ich.org
3. www.emea.europa.eu
4. Z. Y. Yuabova et al., "Genotoxic Impurities : A Quantitative Approach", J. Liq. Chromatogr. Related Technol., 31 (15), pp. 2318-2330 (2008).
5. www.emea.eu.int (document id: CPMP/SWP/5 1 99/02; EMEA/CHMP/QWP/251344/ 2006)
6. L. Mueller et al., "A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity", Regul. Toxicol. Pharm., 44 (3), pp. 198-211 (2006).
7. T. McGovern et al., "Regulation of genotoxic and carcinogenic impurities in drug substances and products", TrAC, Trends in Analytical Chemistry, 25 (8), pp. 790-795 (2006).
8. S. Gorog, "Drug safety, drug quality, drug analysis", J. Pharm. Biomed. Anal., 48 (2), pp. 247-253 (2008).
9. F. Qiu et al., "Identification of pharmaceutical impurities", J. Liq. Chromatogr. Related Technol., 30 (5-7), pp. 877-935 (2007).
10. A. K. Basak et al., "Pharmaceutical impurities : Regulatory perspective for Abbreviated New Drug Applications", Adv. Drug Delivery Rev., 59 (1), pp. 64-72 (2007).
11. G. Chen et al., "Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery", J. Mass Spectrom., 42 (3), pp. 279-287 (2007).
12. C. Szantay et al., "The changing role of NMR spectroscopy in offline impurity identification: A conceptual view", TrAC, Trends in Analytical Chemistry, 25 (8), pp. 806-820 (2006).
13. D. Q. Liu et al., "On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities", J. Pharm. Biomed. Anal., 44 (2), pp. 320-329 (2007).
14. G. Terfloth, "Preparative isolation of impurities", Analysis of Drug Impurities, pp. 215-234 (2007).
15. J. An et al., "A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances", J. Pharm. Biomed. Anal., 48 (3), pp. 1006-1010 (2008).
16. D. P. Elder et al., "Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients", J. Pharm. Biomed. Anal., 48 (3), 497-507 (2008).
17. N. V. V. S. S. Raman, et al., "Development and validation of RP-HPLC method for the determination of genotoxic alkyl benzenesulfonates in amlodipine besylate", J. Pharm. Biomed. Anal., 48 (1), pp. 227-230 (2008).
18. Z. Y. Yuabova et al., "Genotoxic Impurities : A Quantitative Approach", J. Liq. Chromatogr. Related Technol., 31 (15), pp. 2318-2330 (2008).